Funded startups/Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc.

SEC filing

Biotechnology · Rockville, MD

Form D on EDGAR

Amount raised$348.9Msold at filing

Total offering$348.9M

Investors in the raise104count reported to the SEC

FiledMar 4, 2026first sale Feb 17, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Bob B. HolmenDirector

Kristian B. HumerDirector

Christopher GerryExecutive Officer, Director

Phillip B. DonenbergDirector

Anand Kiran ParikhExecutive Officer, Director

Tom RicksDirector

Josiah CraverExecutive Officer

Executive officers, directors and promoters as listed on the Form D.